Septic Shock and Corticosteroids
- 20 August 1981
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 305 (8) , 456-458
- https://doi.org/10.1056/nejm198108203050810
Abstract
The use of a massive dose of a glucocorticoid in the patient with septic shock remains controversial. Some physicians believe strongly that corticosteroids favorably influence the outcome in a patient in whom septic shock is present or developing, whereas others regard the data in support of such therapy as insufficient in view of the potential risks. Although some controlled clinical studies have shown favorable effects of massive doses of corticosteroids on morbidity and mortality in septic shock, many have not.1 The Food and Drug Administration recently reviewed the indications for the use of corticosteroids in septic shock, focusing on the . . .Keywords
This publication has 13 references indexed in Scilit:
- Corticosteroids block binding of chemotactic peptide to its receptor on granulocytes and cause disaggregation of granulocyte aggregates in vitro.Journal of Clinical Investigation, 1981
- Release of Inflammatory Mediators from Stimulated NeutrophilsNew England Journal of Medicine, 1980
- Reduction by Cimetidine of Serum Parathyroid Hormone Levels in Uremic PatientsNew England Journal of Medicine, 1980
- Prostaglandins: Interactions with platelets and polymorphonuclear leukocytes in hemostasis and inflammationThe American Journal of Medicine, 1980
- Survival of primates in LD100 septic shock following steroid/antibiotic therapyJournal of Surgical Research, 1980
- Elevated Thromboxane Levels in the Rat during Endotoxic ShockJournal of Clinical Investigation, 1980
- Corticosteroids inhibit complement-induced granulocyte aggregation. A possible mechanism for their efficacy in shock states.Journal of Clinical Investigation, 1979
- Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage.Journal of Clinical Investigation, 1978
- Endotoxin, prekallikrein, complement and systemic vascular resistanceThe American Journal of Medicine, 1975
- Clinical Trial Design in Studies of Corticosteroids for Bacterial InfectionsAnnals of Internal Medicine, 1974